Common questions

Vilon is the dipeptide Lys-Glu (KE). Its molecular formula is C₁₁H₂₁N₃O₅ and its molar mass is 275.30 g/mol. It is the KE short-peptide component in the Thymalin literature and one of several Khavinson-class short peptides.

The featured first-party oral product contains 1 mg Lys-Glu per enteric capsule. The product page recommends morning use. No validated universal daily dosing schedule has been published in a human trial.

Khavinson-class peptide practice commonly follows short-course on/off rhythms with multi-month pauses, often 4-6 months off. This is practice, not a validated Vilon RCT schedule.

No human trial establishes a reliable onset window for Vilon. The product page frames the effect as cumulative; no peer-reviewed onset curve exists.

Enteric coating is designed to release the capsule in the small intestine, where PEPT1 is the major transporter for di- and tripeptides. However, gastric acid is not the only or proven limiting mechanism; luminal peptidase hydrolysis remains a real uncertainty. No published human study reports the intact-KE bioavailability percentage.

Vilon is associated with the broader Thymalin peptide complex in the literature, so the two are often discussed together. Pinealon is a different tripeptide linked in secondary accounts to Russian sport. Combinations should be approached conservatively and with monitoring, not stacking for effect.

Formal human safety data are sparse in the retrieved corpus. Stop use and consult a clinician if you experience allergic symptoms, gastrointestinal distress, or unexpected immune changes.

Vilon is not equivalent to EPO or androgens. Its performance hypothesis rests on immune, coagulation-fibrinolysis, and microvascular mechanisms. No direct Vilon performance trial in athletes has been recovered.

No direct Vilon trials for COVID or Long COVID have been published. The biological context, thymic aging and immune dysregulation, is plausible, but any use should be framed as experimental, not treatment.

Oral capsules should be stored in a cool, dry place away from heat and moisture. No Vilon-specific validated stability or reconstitution SOP was recovered; follow the actual vial/COA protocol rather than importing generic timing.